With three sons with Duchenne MD, columnist Betty Vertin has little time for housework, making her regret not giving the other kids chores.

Columnist Robin Stemple struggles to feel grateful on difficult days with FSHD, but still tries to recognize his many ...

The FDA updated prescribing information for Elevidys with new safety warnings and limiting its use to DMD patients who can ...

New research shows DMD is marked by abnormalities in muscle development in the womb, supporting the potential of a therapy ...

Columnist Shalom Lim reflects with gratitude on how he's found purpose by supporting other Singaporeans on their own health ...

A Phase 1/2 clinical trial testing SRP-1003 for myotonic dystrophy type 1 is progressing with higher doses as planned.

Columnist Betty Vertin's track career ended years ago, but she never stopped lifting weights — only now its the emotional weight of Duchenne.

Agamree is as effective as traditional corticosteroids at preserving walking ability but carries a lower risk of side effects, data suggest.

Exon-skipping therapies Amondys 45 (casimersen) and Vyondys 53 (golodirsen) show “positive and encouraging trends” for people with Duchenne muscular dystrophy (DMD), even though top-line results from ...

When in the course of human events, it becomes necessary to make choices, we must first consider our options. Congratulations! By reading these words, you have made a choice to crawl into my brain ...